awakn life sciences

Weekly Psychedelic Links - December 2022

12.2.22

Cannabis

  • Biden Signs Marijuana Research Bill, A Historic First For Federal Cannabis Reform (Marijuana Moment)

  • Idaho Plans for Medical Cannabis Legalization on the Ballot in 2024 (High Times)

  • Ohio Senate Votes To Remove Marijuana Paraphernalia Convictions From Criminal Records And Allow Broader Expungement (Marijuana Moment)

  • Police in India Say Rats Ate More Than 1,100 Pounds of Confiscated Weed (High Times)

  • Young Americans Are Twice As Likely To Smoke Marijuana Than Cigarettes, New Gallup Data Shows (Marijuana Moment)

  • New Federal Job Applications Won’t Ask About Most Marijuana Use Unless It Was Within The Past 90 Days (Marijuana Moment)

  • Many People with Bipolar Disorder Use Cannabis. It May Sometimes Help (Scientific American)

  • University Researchers Exploring Cannabis As A Treatment For Covid-19 (Forbes)

  • New York’s illicit weed products are weak and full of toxins, study finds (Leafly)

  • Medical Marijuana Legalization Linked To Reduced Opioid Use By Cancer Patients, American Medical Association Study Finds (Marijuana Moment)

  • Pennsylvania Starts Program Providing Financial Assistance to Low-Income Cannabis Patients (High Times)

  • Wedding Guest Files Lawsuit Over Pot-Infused Reception Food (High Times)

  • These States Almost Legalized Marijuana In 2022 (Marijuana Moment)

LSD

  • Many Trips, Diminishing Returns: Cross-Tolerance Between LSD and DOI (Psychedelic Science Review)

  • Former CEO Sues Company That Fired Him for Microdosing LSD in an Investor Meeting (Futurism)

Magic Mushrooms

  • DEA Proposes Even Higher 2023 Production Quotas For Psychedelics Like MDMA And Psilocyn (Marijuana Moment)

  • Non-profit Organization Marches on Canadian Capital To Fight for Therapeutic Mushrooms (High Times)

MDMA

  • The man who took 40,000 ecstasy pills (The Face)

  • Climate Lessons from Cambodia’s Illegal MDMA Market (TalkingDrugs)

Ayahuasca

  • Why Ayahuasca Is Miley Cyrus' 'Favorite' Drug (And How It Supported Her Veganism) (Benzinga)

  • After closing its doors in Canterbury, a church serving hallucinogenic tea vows to reopen elsewhere (NHPR)

  • Ceremonial Ayahuasca in Amazonian Retreats: Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study (Chacruna)

Synthetic Cannabinoids

  • Prison “K2”: The Hidden Center of a Chaotic New Drug War (Filter)

Ketamine

  • Laid-off workers can now get a free month of ketamine-assisted therapy services to help with their mental health (Fortune)

  • Low-dose ketamine may reduce shivering following spinal anesthesia (Physicians Weekly)

  • Ketamine for Depression Poses “Significant Risk to the Public” (Mad in America)

  • Study shows how ketamine administration starkly changes neuronal activity patterns in the brain (News-Medical.net)

Miscellaneous

  • Berkeley, California Officials Approve Psychedelics Decriminalization Resolution Amid Pushback From Reform Advocates (Marijuana Moment)

  • Colombian And Mexican Presidents Announce International Effort To Reshape Drug Policy, Condemning ‘Failure’ Of Prohibition (Marijuana Moment)

  • Colorado Governor To Appoint Psychedelics Advisory Panel After Voters Approve Legalization Ballot Measure (Marijuana Moment)

  • Why the “Psychedelic Renaissance” is just Colonialism by Another Name (DoubleBlind)

  • Could the Latest Science on Psychedelics Revolutionise the Way We Understand Our Minds? (Men's Health)

12.9.22

Cannabis

  • Brittney Griner released from Russian detention in prisoner swap (Leafly)

  • Legalization Amendment To Be Added to Missouri Constitution (High Times)

  • New Jersey Marijuana Regulators Approve Rules For Public Cannabis Consumption Areas (Marijuana Moment)

  • Colombian Senate Approves Marijuana Legalization Bill, Bringing Country Closer To Ending Prohibition (Marijuana Moment)

  • Study: Cannabis Has ‘Uniquely Beneficial Effects’ on People With Bipolar Disorder (High Times)

  • Pain relief from marijuana comes from a belief it helps, study finds (CNN)

  • Delivery is in the works for New York’s new legal weed stores (Leafly)

  • Children are ditching alcohol for marijuana, as 20-year national US study shows a 245% increase (EurekAlert!)

  • Oregon recalls thousands of cannabis products over pesticide concerns (Marijuana Business Daily)

  • Minnesota Files Lawsuit Against Several Companies for Illicit Edible Sales (High Times)

  • As Congress Stalls On Marijuana Banking, New Report Details Public Safety Risk Of Cash-Intensive Dispensaries (Marijuana Moment)

  • NORML Report Highlights Citywide Policies Depenalizing Marijuana Law Enforcement (NORML)

  • Study: ‘Significant’ negative association between medical cannabis sales, alcohol (Marijuana Business Daily)

  • Dispensaries’ Cashless ATM Transactions Get The Ax (High Times)

  • Connecticut: Governor Announces Intent to Expunge 40,000+ Marijuana-Related Convictions (NORML)

  • Biden’s Health Secretary Shares Marijuana Scheduling News At 4:20—Again (Marijuana Moment)

  • Marijuana packaging rebrands can draw consumers, create cohesion, reflect values (Marijuana Business Daily)

  • Trend Sees Brands Pairing Top-Shelf Weed, Fine Dining (High Times)

LSD

  • Study on LSD microdosing uncovers neuropsychological mechanisms that could underlie anti-depressant effects (PsyPost)

Magic Mushrooms

  • Portlanders Explain Why They’re Waiting in Line for Psychedelic Mushrooms (Willamette Week)

  • Study suggests psilocybin increases mindfulness, especially when accompanied by mystical experiences (PsyPost)

  • Amsterdam’s Last Shroom Lounge (DoubleBlind)

  • Diamond Therapeutics completes Phase I clinical study of low-dose psilocybin in healthy human subjects (PR Newswire)

  • Oregon store allegedly selling psychedelic mushrooms raided (The Seattle Times)

MDMA

  • MDMA may be available for medical treatment "as soon as 2024" in US hospitals (Mixmag)

  • Wastewater data shows 286% increase in ecstasy use during pandemic (Healio)

  • Abuse Potential: Considerations for Rescheduling MDMA and Psychedelics (Psychedelic Science Review)

DMT

Ayahuasca

  • A Canadian psychedelic drug company has created medical grade ayahuasca (Toronto Star)

  • Modulatory Effects of Ayahuasca on Personality Structure in a Traditional Framework (Chacruna)

  • Declaration of The 4th Brazilian Indigenous Ayahuasca Conference (Chacruna)

Ketamine

  • Now Companies Can Buy Insurance To Cover Ketamine Therapy for Employees (Lucid News)

  • Using Ketamine to Treat Anorexia (Psychology Today)

  • Meta-Analysis of Intravenous vs Intranasal Ketamine (Psychiatric Times)

  • Low-dose Ketamine Effective In Reducing The Incidence Of Shivering Following Spinal Anesthesia (Medical Dialogues)

Miscellaneous

  • MAPS Found Liable in Wrongful Death Lawsuit (Lucid News)

  • Most States Will Legalize Psychedelics By 2037, Analysis Published By American Medical Association Predicts (Marijuana Moment)

  • When virtual reality meets psychedelic therapy (Mashable)

  • How Will Our Value Systems Affect The Psychedelic Movement? (Maps of the Mind)

  • We’re rushing the use of psychedelics as medicine, researchers say (New Scientist)

  • Awakn Makes Its Case To Investors (Lucid News)

  • Punk Ethos & Psychedelic Practice (Maps of the Mind)

12.16.22

Cannabis

  • Recreational Weed Now Legal in Missouri (High Times)

  • Connecticut: Adult-Use Cannabis Sales to Begin Next Month (NORML)

  • New Hampshire GOP And Democratic House Leaders Team Up On Marijuana Legalization Bill For 2023 (Marijuana Moment)

  • Here’s how New York’s legal weed delivery will work (Leafly)

  • Teen Marijuana Use Remained Stable In 2022, Despite More States Legalizing And Lifting Of Pandemic Restrictions (Marijuana Moment)

  • Kansas City: Officials Dismiss Hundreds of Marijuana Cases Following Statewide Legalization Vote (NORML)

  • Kansas Lawmakers Plan To Introduce Medical Cannabis Legalization Bill (High Times)

  • Prosecution collapses against execs caught up in CannTrust cannabis scandal (CBC)

  • Texas Activists Turn In Signatures To Put Marijuana Decriminalization Back In Voters’ Hands After City Council Repeal (Marijuana Moment)

  • Massachusetts To Add Lessons on Weed Impairment to Driver’s Ed (High Times)

  • Nearly 2 Million Marijuana Convictions Have Been Pardoned Or Expunged In The U.S. In The Past Five Years, New Report Shows (Marijuana Moment)

  • Australian Residents Could Save $850 Million Annually if Cannabis is Decriminalized (High Times)

  • Marijuana Legalization Reduces Arrests Even In States That Already Decriminalized, American Medical Association Study Finds (Marijuana Moment)

LSD

  • Up to 9% of LSD and psilocybin users report reoccurring effects after drug has worn off (PsyPost)

  • Gut Feeling: Links Between LSD, Endocannabinoids, and the Microbiome (Psychedelic Science Review)

Magic Mushrooms

  • Florida halts amanita muscaria sales at nation’s only brick-and-mortar retailer (Leafly)

  • COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP (Psychedelic Alpha)

  • Here’s why police are raiding psychedelic mushroom stores in major cities (Leafly)

  • Rat Study Examines Psilocybin as Treatment for Autism Spectrum Disorder (High Times)

MDMA

  • The History and Benefits of MDMA, the New Tool in Mental Health Again (Daily Kos)

DMT

  • Experiencing a Changa Ceremony at an Oakland Plant Medicine Church (Lucid News)

Ayahuasca

  • Aaron Rodgers says doing psychedelic drug ayahuasca helped him overcome his ‘fear of death’ (The Independent)

5-MeO-DMT

  • UCL To Lead First-Ever Brain Imaging Study Among Psychedelic Retreat Participants (High Times)

  • PsyBio Therapeutics Takes Initial Step to Help Protect the Sonoran Desert Toad as it Files Three New Provisional Patent Applications, Including Intellectual Property Protection for the Biosynthetic Production of 5-MeO-DMT (Psychedelic Alpha)

Peyote

  • Inside the battle to save the sacred peyote ceremony: ‘We’re in dire straits’ (The Guardian)

Novel Psychoactive Substances

  • Israeli Based Biotech Company Clearmind Completes IND-Enabling Studies for CMND-100 (Psychedelic Alpha)

Ketamine

  • Ketamine plus therapy could help treat alcoholism, say researchers (The Guardian)

Miscellaneous

  • Verdict in Lawsuit Assigns MAPS 25% Liability and $1M in Damages (Lucid News)

  • New center takes multidisciplinary approach to the study of psychedelics (University of Michigan)

  • It’s Not Just About Pot. Our Entire Drug Policy Needs an Overhaul. (The New York Times)

  • The Effects of Sleep Deprivation on a Psychedelic Experience (Sam Woolfe)

  • Would You Be Friends With Your Friends if You Didn’t Do Drugs Together? (VICE)

  • Why is Gender-Affirming Care Needed in the Psychedelic Space? (Chacruna)

  • How Many Likes Does it Take to be a Psychedelic Thought Leader? (Lucid News)

12.23.22

Cannabis

  • First words from Brittney Griner: Thanks Biden, vows to help free others (Leafly)

  • Federally Funded Study Finds Teen Use Rates Largely Unchanged by Legalization (NORML)

  • Canada Destroys a Record Amount of Cannabis (High Times)

  • District of Columbia: Council Members Advance Legislation to Expunge Tens of Thousands of Marijuana Convictions (NORML)

  • Afroman Announces 2024 Run for President (High Times)

  • Twitter Stops Suggesting People Who Search For ‘Marijuana’ May Need Drug Treatment (Marijuana Moment)

  • Canada’s Cannabis Legalization Is Working Effectively, Annual Survey Suggests (Forbes)

  • New Washington Bill Would Allow Interstate Marijuana Commerce (Marijuana Moment)

  • New Report Analyzes Medical Pot Patients’ Consumption Habits (High Times)

  • Majority Of Texas Voters Back Marijuana Legalization, And Three In Four Support Decriminalization, Poll Finds (Marijuana Moment)

LSD

  • How LSD evolved from CIA mind-control drug to counterculture emblem (Leafly)

Magic Mushrooms

  • Quebec covers psilocybin therapy under medical insurance in historic first (Leafly)

  • Oregon Psilocybin Entrepreneurs Navigate Business Requirements (Lucid News)

Ayahuasca

  • Canadian Company Announces Ayahuasca Pills (Chacruna)

  • Music and ayahuasca’s role in treating substance use disorders in men (UC Riverside)

Datura

  • Weed responsible for hallucinogenic spinach recall identified as thornapple (The Guardian)

Miscellaneous

  • New Bill Tries to Decriminalize Psychedelics in California—Again (DoubleBlind)

  • The Myth of the Psychedelic Santa (Lucid News)

  • U.K. Police Chiefs Call for Decriminalization of First-Time Drug Offenses (High Times)

  • Israel-Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute (Psychedelic Alpha)

  • Placebo Problems: Boundary Works in the Psychedelic Science Renaissance (Chacruna)

12.30.22

Cannabis

  • Record Number of Scientific Papers Published About Cannabis in 2022 (NORML)

  • Washington, D.C. Passes Bill To Expand Medical Weed Sales (High Times)

  • Google Ends Ban On Advertising Certain Hemp And CBD Products In Parts Of U.S. (Marijuana Moment)

  • Clinical Trial Finds Cannabis Oil is Well-Tolerated, Effective Insomnia Treatment (High Times)

  • Snoop Dogg’s Death Row Records To Launch Its Own Cannabis Brand (Forbes)

  • California Gov. Gavin Newsom Pardons 10, Some Cannabis Convictions (High Times)

  • A dying US cancer patient used cannabis to ease pain. His hospital called the police (The Guardian)

  • South Dakota Activists File Measure That Could Put Marijuana Legalization On Ballot For Third Election In A Row (Marijuana Moment)

  • Is legal weed doomed to be run by big business? (Vox)

  • Texas Marijuana Activists Submit Enough Signatures To Challenge Local Decriminalization Repeal, While Another City’s Reform Faces Lawsuit (Marijuana Moment)

Magic Mushrooms

  • A single dose of psilocybin improves depression in treatment-resistant patients, but with adverse effects (PsyPost)

  • Psilocybin Therapy For Autism-Like Disorder Receives Approval For Phase 2a Clinical Trial (The Dales Report)

  • Do Shrooms Go Bad? (DoubleBlind)

MDMA

  • MDMA Is Getting Super Popular Among Rich, Young Indians (VICE)

  • VA Report Says Psilocybin And MDMA Show Therapeutic ‘Promise’ For Veterans’ Mental Health Conditions (Marijuana Moment)

DMT

  • Phase 2a study initiated to examine synthetic DMT for treatment-resistant depression (Healio)

Ayahuasca

  • “Nobody Wants A Synthetic-Only Future”: Filament Health Is Formulating Natural Psilocybin And Standardizing Ayahuasca (Healing Maps)

Novel Psychoactive Substances

  • Tripping Without The Trip: Non-Hallucinogenic Psychedelics (Benzinga)

Ketamine

  • Much remains unknown about using ketamine to treat depression—and Colorado doesn't regulate it (The Denver Post)

Miscellaneous

  • New York Lawmakers File Psychedelics Legalization Bill For 2023 (Marijuana Moment)

  • Psychedelics Like Psilocybin Are Now Legal In Colorado With Governor’s Proclamation On Voter-Approved Ballot Measure (Marijuana Moment)

  • The Multidimensional Worlds of Mariela de la Paz (DoubleBlind)

  • Minnesota Medical Association Endorses Decriminalizing Drugs (Marijuana Moment)

  • Psychedelic therapies are on the horizon, but who will administer the drugs? (NBC News)

  • Psychedelic drugs may launch a new era in psychiatric treatment, brain scientists say (NPR)

  • Psychedelics Are Surging—at the Expense of Indigenous Communities (The Daily Beast)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 2.18.22

Cannabis

  • Virginia Senate Votes To Start Recreational Marijuana Sales This September Through Current Medical Dispensaries (Marijuana Moment)

  • Sha’Carri Richardson, Suspended Over Marijuana, Suggests Racist Double Standard After Olympics Lets Russian Skater Compete Amid Doping Scandal (Marijuana Moment)

  • Israel Announces New Cannabis Decriminalization Plans (High Times)

  • Apple Secretly Joined Amazon In Advancing Commercial Cannabis Reform (Forbes)

  • New York Lawmakers Send Marijuana Licensing And Equity Bill To Governor’s Desk (Marijuana Moment)

  • South African Government to Fast Track Cannabis Reform Regulations (High Times)

  • D.C. Mayor Signs Bill To Let Older Patients Get Medical Marijuana Without Doctors And Create 4/20 Cannabis Tax Holiday (Marijuana Moment)

  • Marijuana for trauma: Report shows positive effects of medical cannabis (The Jerusalem Post)

  • Hawaii Senate Committee Approves Bill To Legalize Marijuana For Senior Citizens 65 And Older (Marijuana Moment)

  • Bill To Create State-Run Marijuana Shops In New Hampshire Approved By House (Marijuana Moment)

  • Alabama Senators Approve Marijuana Decriminalization And Expungements Bill In Committee (Marijuana Moment)

  • South Dakota Lawmakers Approve Marijuana Legalization And Taxation Bills In Committee (Marijuana Moment)

  • WA researchers look at potential to use medicinal cannabis for weight loss (Australian Broadcasting Corporation)

  • GOP Missouri Lawmaker Unveils Wide-Ranging Marijuana Legalization Bill As Others Pursue 2022 Ballot (Marijuana Moment)

  • Kentucky Democrats File Bills To Legalize Marijuana (Marijuana Moment)

  • Lawmakers, Cops Consider Adult-Use Cannabis Legalization in Pennsylvania (NORML)

  • Wyoming Legislators Introduce Cannabis Decriminalization Bill (High Times)

  • Maryland Lawmakers Take First Step To Putting Marijuana Legalization On 2022 Ballot With Hearing On Two Bills (Marijuana Moment)

  • New York Senate OKs bill to allow hemp farmers to grow adult-use marijuana (Marijuana Business Daily)

  • Majority Of Arkansas Voters Back Cannabis Legalization (High Times)

  • IRS Official Clarifies That Medical Marijuana Is Not Tax-Deductible Under Federal Law After Misstatement (Marijuana Moment)

  • Proposed Bill Could Protect Employees in Colorado who Use Cannabis (High Times)

  • Hemp-Reinforced Bobsled and Luge Tracks Debut at Winter Olympics in Beijing (High Times)

LSD

  • Another trial finds no evidence LSD microdosing does anything (New Atlas)

  • LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility (Beckley Foundation)

  • New study addresses the question; ‘Can LSD boost creativity?’ (leafie)

Magic Mushrooms

  • Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients, Study Shows (Johns Hopkins)

  • Top Italian Court Blocks Marijuana And Psilocybin Referendum From Going Before Voters (Marijuana Moment)

  • Psilocybin use associated with lowered odds of having been arrested, study finds (PsyPost)

  • Oklahoma Lawmakers Approve Psilocybin Decriminalization And Research Bill In Committee (Marijuana Moment)

  • Mushroom rabbi grows ceremonial psilocybin for Denver congregation — but is that legal? (The Denver Post)

  • Hawaii Senators Approve Psilocybin Task Force Bill In Committee, With Decriminalization Measures Still Pending (Marijuana Moment)

  • Oregon proposes only using one type of mushroom for new psilocybin system, and no pills (OPB)

  • Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism (Psilocybin Alpha)

  • These Four Companies Want to Take You on a Psychedelic Voyage in Oregon (Willamette Week)

  • No Need for Magic Mushrooms? Producing Synthetic Psilocybin from Bacteria and Yeast (Truffle Report)

  • Psyched Wellness Announces Key Findings from the 90-Day Oral Toxicity Study on AME-1 (Psilocybin Alpha)

MDMA

  • Bar-Goers Were Poisoned by Ecstasy-Laced Champagne, German Police Say (Gizmodo)

DMT

Ayahuasca

  • Deontay Wilder contemplates using ayahuasca to help decide his boxing future (leafie)

  • When Is Drinking Ayahuasca a Religious Experience? (Reason)

5-MeO-DMT

  • More Companies Embrace 5-MeO-DMT to Create Therapies (Lucid News)

Peyote

  • Calling on Federal, State, and Local Governments to Protect and Respect Peyote (Lophophora williamsii) and its Byproducts (Chacruna)

  • How peyote — used as a ceremonial, legal medicine — helped heal one family’s grief (Rocky Mountain PBS)

Novel Psychoactive Substances

  • Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules (Psilocybin Alpha)

  • Awakn Files Patent For A New Class Of Entactogen-Like Molecules (Psilocybin Alpha)

Synthetic Cannabinoids

  • Report finds too many New Zealanders are dying from preventable drug overdoses (Newshub)

Nitrous Oxide

  • Doctors warn of emerging public health issue from recreational use of laughing gas (Irish Examiner)

Ketamine

  • Ketamine No Better Than Placebo for Reducing Suicidal Ideation in Depression (Mad in America)

  • Ehave, Inc. Launches KetaDASH, Its In-Home Ketamine Therapy In The San Francisco And Sacramento Market (GlobeNewswire)

  • FDA: Safety Concerns With Compounded Ketamine Nasal Spray (MPR)

  • PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation (Psilocybin Alpha)

Miscellaneous

  • Judge Grants Hearing for Opposition to DEA Proposal to Criminalize 5 More Psychedelics (Psychedelic Spotlight)

  • MAPS Accepts $500,000 Donation From Atai Life Sciences’ Philanthropy Arm (Forbes)

  • Maryland Senators Propose Free Psychedelics for Veterans with PTSD (Truffle Report)

  • Psychedelics Open Opportunity to Study Synesthesia (Lucid News)

  • Trauma and Vulnerability to Suggestion: Redefining How We Understand Consent (Psychedelics Today)

  • The Psychonaut’s Guide to Kabbalah and Spiritual Journeying (DoubleBlind)

  • What Are the Prospects for Canada’s Federal Drug Decriminalization Bill? (Filter)

  • Maryland Lawmakers Work To Decriminalize Drug Paraphernalia (Marijuana Moment)

  • The 5 Craziest Places On Earth to Do Psychedelics (DoubleBlind)

  • The Religious Uses of Licit and Illicit Psychoactive Substances in a Branch of the Santo Daime Religion (Chacruna)

  • “Largest-Ever” Harm Reduction Ad Campaign Demands Services, Honors the Dead (Filter)

  • Naming and shaming drug users is focus group fodder – Labour must do better (LabourList)

  • Co-Creating a Psychedelic Commons: A Commoner’s Guide (Chacruna)

  • Meet the 16 Most Influential Women Shaping the Future of Psychedelics (Business Insider)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.28.22

Cannabis

  • Thailand Becomes First Country in Asia to Decriminalize Marijuana (TIME)

  • New York medical cannabis approved for ‘any’ condition a doctor recommends (Leafly)

  • Mississippi: Lawmakers Advance Medical Cannabis Access Bill to Governor’s Desk (NORML)

  • Amazon Endorses Federal Cannabis Legalization (High Times)

  • Europeans choosing cannabis over ecstasy (The Portugal News)

  • Delaware Lawmakers Approve Marijuana Legalization Bill In Committee Vote (Marijuana Moment)

  • Arkansas voters could see 3 recreational marijuana initiatives on ballot (Marijuana Business Daily)

  • Cannabis Events Come Out of Hiding in New York City (The New York Times)

  • North Dakota recreational marijuana measure fails to qualify for ballot (Marijuana Business Daily)

  • Wisconsin Republicans Announce Limited Medical Marijuana Legalization Bill (Marijuana Moment)

  • Legal Cannabis Opens a Pandora’s Box of Equity Issues (Capital and Main)

  • Ohio Lawmakers Will Be Forced To Consider Marijuana Legalization As State Validates Activist Signatures (Marijuana Moment)

  • Active Ingredient in Cannabis Protects Aging Brain Cells (Neuroscience News)

  • Majority Of Americans Say They’d Vote For A Politician Who Smokes Marijuana, Poll Finds (Marijuana Moment)

  • What Happens When You Quit Cannabis? (IFLScience)

  • Missouri Marijuana Legalization Measures Take Differing Approaches to Expungement (Marijuana Moment)

  • Minnesota Groups Bind Together to Oppose Legal Cannabis (High Times)

  • Don’t Feed Marijuana Buds To Donkeys, New Study Warns (Marijuana Moment)

  • South Dakota: House Lawmakers Move to Repeal Citizen-Initiated Home Cultivation Rights (NORML)

LSD

  • FDA clears phase 2b study of LSD treatment for generalized anxiety (Healio)

Magic Mushrooms

  • No difference between psilocybin microdosing and placebo, trial finds (New Atlas)

  • Colorado Activists File Revised Ballot Initiatives To Legalize Psilocybin And Establish ‘Healing Centers’ (Marijuana Moment)

  • Oregon Lawmakers File Psilocybin Equity Bill As State Implements Legal Use Program (Marijuana Moment)

  • Oklahoma Republicans File Bills To Decriminalize Psilocybin And Encourage Research On Medical Benefits (Marijuana Moment)

  • Numinus Identified as a Licensed Psilocybin Supplier by Health Canada (Psilocybin Alpha)

  • Psilocybin: Following in the Footsteps of Cannabis Along the Path to Legality (JD Supra)

  • Psyched Wellness Provides Update on Anti-Inflammatory Study with the National Research Council of Canada (Psilocybin Alpha)

  • How is Oregon Preparing for the Facilitated Use of Psilocybin? (Lucid News)

  • Red Light Holland’s Partner CCrest Laboratories Approved By Health Canada to Supply Psilocybin to the Special Access Program (Psilocybin Alpha)

  • Diamond Therapeutics Looks At Low-Dose Psilocybin (The Dales Report)

  • Mydecine Partners with Combat Stress to Treat Post-Traumatic Stress Disorder in Veterans (Psilocybin Alpha)

DMT

  • Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy as Part of its Psychedelic Drug DMT Intellectual Property (Psilocybin Alpha)

5-MeO-DMT

  • A Psychedelic Craze Has Taken Hold Among The Rich, Toad Venom (Baller Alert)

Novel Psychoactive Substances

  • The Future of Psychedelic Medicine Will Be Drugs You’ve Never Heard Of (VICE)

  • Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a Broad Range of Addictions (Psilocybin Alpha)

Ketamine

  • New study indicates ketamine is less effective than electroconvulsive therapy for severe depression (PsyPost)

  • Ketamine Intravenous Therapy Shown to Improve Depression, Reduce Suicidal Ideation (Psych Central)

  • Have We Eliminated Stigma Surrounding Ketamine-Assisted Treatment? (Volteface)

Miscellaneous

  • Missouri Legislators Introduce Bill to Give Terminally Ill Patients Access to Psychedelics (DoubleBlind)

  • Virginia House Committee Pushes Back Psychedelics Decriminalization Bill Until 2023, But Senate Proposal Still Pending (Marijuana Moment)

  • Lawmakers Propose Study of Natural Psychedelics for Mental Health Use (Westword)

  • Introducing Vital: Immersive, Inclusive, and Personal Psychedelic Training for Professionals (Psychedelics Today)

  • Psychedelic Perceptions in 2021: Popular Culture & Controversy (Psilocybin Alpha)

  • Family Tripping: How Multigenerational Psychedelic Drug Experiences Can Provide Connection (Everything Zoomer)

  • Psychedelic Capital: Public vs. Private Markets (Truffle Report)

  • Sensible policy on psychedelic drugs is growing more common (The Economist)

  • Inside the Growing Wellness Trend of Psilocybin Mushroom Microdosing (The Hollywood Reporter)

  • Hallucinogen chemistry guides antidepressant drug discovery (Chemical and Engineering News)

  • Decriminalize Nature and Students For Sensible Drug Policy Create a Community Healing Alliance (High Times)

  • Have You Taken Psychedelics? Participate In The Canadian Psychedelics Survey Sponsored By MAPS PBC (The Dales Report)

  • Laganja Estranja’s Psychedelic Life (DoubleBlind)

  • Psychedelics and Parkinson’s Disease: Improving Patient Quality of Life (Truffle Report)

  • Psychedelic and Plant Medicines: A Portal to Transformative Realms of Possibility (Nonprofit Quarterly)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.7.22

Cannabis

  • Sadiq Khan plans pilot to ‘decriminalise’ minor cannabis offences in London (The Guardian)

  • Legal recreational marijuana sales begin in Montana (KPAX)

  • Federal Marijuana Monopoly Finally Ends As Two Companies Harvest Cannabis Approved By DEA (Marijuana Moment)

  • New year rings in key changes to state marijuana markets (Marijuana Business Daily)

  • GOP-Controlled New Hampshire House Votes To Legalize Marijuana Possession And Cultivation (Marijuana Moment)

  • Colorado: Governor Issues Pardons to Over 1,300 Marijuana Offenders (NORML)

  • Wyoming Marijuana Activists Turn Focus To 2024 Ballot For Decriminalization And Medical Cannabis Initiatives (Marijuana Moment)

  • The top cannabis research studies of 2021 (Leafly)

  • Incoming Virginia GOP Governor Won’t ‘Overturn’ Legal Marijuana Possession, But Casts Doubt On Sales (Marijuana Moment)

  • Top Kansas Democrats Unveil Plan To Put Medical And Adult-Use Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

  • Two recreational marijuana initiatives might appear on Oklahoma ballot in fall (Marijuana Business Daily)

  • Iowa Democrats Unveil Marijuana Resolution To Put Legalization On Ballot For Voters To Decide (Marijuana Moment)

  • New Republican-Led Bill Would Legalize Medical Cannabis In Kentucky (Marijuana Moment)

  • South Dakota Lawmakers Prepare Dozens Of Cannabis Reform Bills (High Times)

  • Marijuana Decriminalization Reduces Arrests And Racial Disparities In Law Enforcement, Study Finds (Marijuana Moment)

  • Tiny but mighty: Micro-cultivators dominated 2021 (Leafly)

  • The cost of medical marijuana in Louisiana (KSLA)

  • Israeli startup a go-to resource in medical cannabis world (I24News)

  • Oklahoma Pot Farm Slapped with RICO From Next Door Neighbor (High Times)

  • Cannabis users report higher quality of life than non-users (Leafie)

Magic Mushrooms

  • Washington Psilocybin Bill Would Legalize Supported Adult Use (Bill of Health)

  • COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology (Psilocybin Alpha)

  • New Hampshire Bipartisan Bills Want to Reduce Penalties on Psilocybin, Other Drugs (Truffle Report)

  • Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder (Psilocybin Alpha)

  • Filament Health Announces Health Canada Approval for Phase II Trial Administering New Psilocybin Microdose Formulation (Psilocybin Alpha)

  • Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

  • Psilocybin therapy options could expand in Hawaiʻi (Hawai'i Public Radio)

MDMA

  • Drug testing: Dramatic drop in bath salts being sold as MDMA (Radio New Zealand)

  • Microdosing MDMA: What Research Says About Doing It For Mental Health Issues (Healing Maps)

DMT

  • Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee (Psilocybin Alpha)

Ayahuasca

  • IRS defends denial of Des Moines church's tax-free status over use of psychedelic drug (KCCI)

  • Anti-Drug GOP Senator Helps Psychedelic Church With Fight Against DEA And IRS (Marijuana Moment)

Iboga

  • National Institute on Drug Abuse to Test Ibogaine For Addiction Treatment (Truffle Report)

  • Caribbean Facility Finds Consistent Success Using Ibogaine for Anxiety and Trauma Treatment (PR Newswire)

Novel Psychoactive Substances

  • MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC (Psilocybin Alpha)

  • Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds (Psychedelic Spotlight)

Synthetic Cannabinoids

  • Using cannabinoids to treat obesity (Medical Xpress)

  • More needs to be done to tackle synthetic cannabinoids, experts say (Stuff.co.nz)

Ketamine

  • Awakn Life Sciences Expands World's First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral Addictions (Yahoo!)

  • PharmaTher Announces Publication of Research Data for KETABET™ (Psilocybin Alpha)

Miscellaneous

  • The Promises and Perils of Psychedelic Health Care (The New York Times)

  • Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy (Psychedelic Spotlight)

  • Magic mushroom companies are on the Nasdaq now. That’s a recipe for a bad trip (The Guardian)

  • Psychedelics Can Change Your View on the Nature of Reality (Psychedelic Spotlight)

  • Psychedelics in 2022: What to Expect (Truffle Report)

  • Fact Check-London Mayor not decriminalising drugs (Reuters)

  • Psychedelics 2021: A Year in Review (Psilocybin Alpha)

  • Will overdose deaths force an end to the US ‘war on drugs’? (Financial Times)

  • Philippines' Duterte says will never apologise for drug war deaths (Reuters)

  • New York Prisons Punished 1,600 People for False Drug Test Results (Filter)

  • Now psychedelics are coming to your medicine cabinet (ISRAEL21c)

  • How Psychedelic Therapy Fuses Indigenous Shamanism With Western Science (IFLScience)

  • Pop Culture Boosts Acceptance of Plant Medicine (GlobeNewswire)

  • Can A Psychedelic Experience Improve 2022? (Reality Sandwich)

  • Psychedelic Drug Policy Reform in 2021: A Year in Review (Psilocybin Alpha)

  • Psychedelics Will Have a Big Presence at SXSW in 2022 (Psychedelic Spotlight)

  • Was 2021 the Year Psychedelics Conquered Capitalism? (Green Entrepreneur)

  • Startup To Host Psychedelic Trips In The Metaverse (Forbes)

  • Is ‘The Trip’ Essential to The Psychedelic Experience? (Psychedelic Spotlight)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.29.21

Cannabis

  • With export restrictions eased, Colombia's medical cannabis business is poised for liftoff (CNN)

  • Federal Survey Identifies Marked Decline in Youth Marijuana Use (NORML)

  • Why did Texas ban Delta-8? (Popular Science)

  • Cannabis products may help treat symptoms of depression, improve sleep, and increase quality of life, study suggests (PsyPost)

  • California Destroys 1M Plants in Marijuana Eradication Campaign (High Times)

  • State Attorneys General Warn About Marijuana-Infused Candy And Snacks Ahead Of Halloween (Marijuana Moment)

  • The Myth of Cannabis-Infused Halloween Candy—Debunked (High Times)

  • Cannabis is one industry that's actually coming out of Covid even stronger (CNN)

  • South Dakota Lawmakers Approve Marijuana Legalization Bill As Activists Pursue 2022 Ballot Initiative (Marijuana Moment)

  • New York: Officials Moving to Clear Over 400,000 Past Marijuana Convictions (NORML)

  • Montana Supreme Court Unanimously Overturns a Pot Conviction, Saying Cops Stopped the Defendant for No Good Reason (Reason)

  • Analysis: ‘Government-Grade’ Marijuana More Closely Resembles Hemp, Has Little in Common with Commercially Available Cannabis (NORML)

  • Florida judge rules online marijuana ordering sites may resume business (Marijuana Business Daily)

  • Louisiana plans to regulate, not ban, delta-8 THC (Marijuana Business Daily)

  • Former Arkansas Lawmaker Launches Campaign To Put Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

  • Maryland: Most Residents Want to Legalize Marijuana for Adult Use (NORML)

LSD

  • Ex-Denver Cop Who Broke Teen's Face for Dancing on LSD to Cost City $1.2 Million (Westword)

Magic Mushrooms

  • Study Finds Psilocybin Improves MDD in Patients With Cancer (Psychiatric Times)

  • Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property (STAT)

  • Italian Activists Turn In More Than Half A Million Signatures For Marijuana And Psilocybin Referendum (Marijuana Moment)

  • Dr. Bronner’s Funds Psilocybin Legalization Effort in Connecticut (High Times)

  • More Evidence of the Chemical Compound Variability in Magic Mushrooms (Psychedelic Science Review)

  • MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias (Psilocybin Alpha)

  • Nova Mentis Earns Psilocybin Orphan Drug Designation in Europe for Fragile X Syndrome (PR Newswire)

MDMA

  • No One Is Wasting Their Ecstasy on Your Kids' Halloween Candy (Reason)

  • MindMed Announces R(-)-MDMA Program to target Social Anxiety Associated with Autism Spectrum Disorder (Psilocybin Alpha)

Ayahuasca

5-MeO-DMT

  • Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial Assessing Safety and Tolerability of Intranasal 5-MeO-DMT (Psilocybin Alpha)

Novel Psychoactive Substances

  • Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin (Psilocybin Alpha)

  • Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease (Psilocybin Alpha)

  • Awakn Life Sciences Identifies New Chemical Series Via Its Drug Discovery Program (Awakn Life Sciences)

  • Marvel Biosciences Announces New Program to Develop Novel Orally Dosed Non-Hallucinogenic Neuroplastic Promoting Compounds (Yahoo! Finance)

Synthetic Cannabinoids

Ketamine

  • European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders (Psilocybin Alpha)

  • Cocaine, ketamine use on the rise: survey (PerthNow)

  • Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology (Psilocybin Alpha)

  • MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE’s Digital Therapeutics Platform (Psilocybin Alpha)

Miscellaneous

  • Canadian entrepreneur gifts $5 million to help create psychedelic research centre for mental health (CTV News)

  • Where the Psychedelic Revolution Is Headed, According to the Guy Who (Arguably) Started It (GQ)

  • Psychedelics Group Issues First Round Of Grants For Community-Based Entheogenic Education In DC (Marijuana Moment)

  • Addressing Abuse in Psychedelic Spaces (Psychedelics Today)

  • North America Continues Leading The Way In Psychedelic Wellness (PR Newswire)

  • Psychedelic Patents Should Be Limited, Harvard Law Experts Say (Psychedelic Spotlight)

  • Could Psychedelics Cure Our Post-Pandemic Depression? (Truffle Report)

  • How Gender Affects the Way We Use Drugs (TalkingDrugs)

  • DC Voters Strongly Support Drug Decriminalization, Poll Finds As Activists Launch Campaign (Marijuana Moment)

  • MAPS Canada’s Data Breach Foreshadows Corporadelic Future (Psymposia)

  • Wavepaths: The Neuroscientist-Founded Company Producing Music For—And As—Psychedelic Therapy (Forbes)

  • Novamind Brings Contract Research To Psychedelic Medicine (Lucid News)

  • Psychedelic Research Beyond Depression & Trauma (Truffle Report)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.